NDC00039-0019-10: CEFOTAXIME SODIUM.
The CEFOTAXIME SODIUM is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR AND INTRAVENOUS, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-117-1986, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR AND INTRAVENOUS |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFOTAXIME EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFOTAXIME SODIUM STERILE USP POWDER FORM 2GM VIAL 10S PG |
| NSN | 6505-01-117-1986 |
| ADMINISTRATION | INTRAMUSCULAR AND INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFOTAXIME SODIUM STERILE USP POWDER FORM 2GM VIAL 10S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFOTAXIME EQUIVALENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |